Gene: CYP2J2
Official Full Name: cytochrome P450 family 2 subfamily J member 2provided by HGNC
Gene Summary: This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and is thought to be the predominant enzyme responsible for epoxidation of endogenous arachidonic acid in cardiac tissue. Multiple transcript variants have been found for this gene. [provided by RefSeq, Jan 2016]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO38321 | CYP2J2 Knockout cell line (HCT 116) | Human | CYP2J2 | 1:2~1:4 | Negative | Online Inquiry |
KO38322 | CYP2J2 Knockout cell line (HEK293) | Human | CYP2J2 | 1:3~1:6 | Negative | Online Inquiry |
CYP2J2 Gene Knockout Cell Lines are specialized cellular models in which the CYP2J2 gene has been intentionally disrupted to facilitate the study of this critical cytochrome P450 enzyme's role in drug metabolism, cardiovascular health, and pathophysiological mechanisms. The CYP2J2 enzyme is primarily known for its involvement in the metabolism of endogenous substrates and pharmacological compounds, thus serving as a significant actor in determining therapeutic outcomes and toxicity profiles.
These knockout cell lines enable researchers to observe the specific physiological changes that occur in the absence of CYP2J2 activity. By silencing this gene, the mechanisms underlying its contributions to drug interactions and cardiovascular functions can be elucidated more clearly. This model is particularly valuable in pharmacological studies aimed at identifying potential drug-drug interactions and understanding the metabolic pathways affecting drug bioavailability and efficacy.
What sets CYP2J2 Gene Knockout Cell Lines apart from alternative models is their engineered precision, which allows for tailored investigations into the specific biochemical pathways associated with CYP2J2 without the confounding effects of enzyme redundancy typically found in vivo. Moreover, these cell lines allow for high throughput screening of new drug candidates, providing an efficient and reproducible platform for preclinical studies.
For researchers and clinicians, the value of these knockout cell lines lies in their ability to streamline research focused on understanding drug metabolism and toxicity, ultimately leading to more informed clinical decisions regarding drug therapies. In addition, these models empower scientists to better explore cardiovascular diseases related to altered CYP2J2 functionality, facilitating innovative therapies.
Our company specializes in developing high-quality biological reagents and tools for cutting-edge research, including the CYP2J2 Gene Knockout Cell Lines. With our commitment to advancing scientific understanding through reliable products, we equip researchers with the necessary resources to drive breakthroughs in pharmacology and toxicology.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.